Heart Failure Management 2026: Precision Medicine to Personalize Care

Thursday, July 16, 2026, 11:00 AM - Sunday, July 19, 2026, 12:00 PM, Amelia Island, FL, Fernandina Beach, FL

Successfully Integrating Novel Drug Therapy in the setting of optimized EBM for CHF Best application of multiple types of devices to optimize outcomes and quality of life in CHF Promoting Close Partnerships with EP and Advanced HF Colleagues Emphasis on Integrated Team Approach to Optimize Delivery of CHF Care Our meeting is driven by expert faculty presentions and complemented by extensive panel discussions and interactive audience involvement. We aim to describe successful integration of current and novel drug therapies and application of multiple devices and invasive procedures to optimize outcomes and quality of life in patients with heart failure.


AMA PRA Category 1 Credits™ (17.25 hours), Non-Physician Attendance Certificate (17.25 hours)

1. Discuss the clinical profile and current definition of heart failure
2. Apply appropriate strategies to optimize use of current and novel drug therapy of heart failure with reduced ejection fraction
3. Understand the latest findings concerning pharmacological approaches to heart failure with mid-range and preserved ejection fraction
4. Describe current therapeutic strategies for cardiac amyloid and hypertrophic cardiomyopathy
5. Discuss management of advanced heart failure with mechanical circulatory support and surgical approaches including left ventricular assist devices and cardiac transplantation
6. Review strategies for implement of hemodynamic monitoring and novel device therapies to control congestion and improve outcomes in patients with heart failure
7. Understand options for electrophysiological interventions to address risk of sudden death and atrial arrhythmias in patients with heart failure
8. Understand current treatment approaches to Pre-Heart failure and risk reduction strategies for risk factors for heart failure using biomarkers and cardiac imaging

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and University of North Carolina Chapel Hill - Division of Cardiology. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The University of Florida College of Medicine designates this Live Activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy
Written refund requests must be received on or before June 16, 2026. A $75 processing fee will be deducted from refund requests. NO REFUNDS WILL BE GIVEN AFTER June 16, 2026. Substitutions are allowed with advance notice. Refund and/or substitution requests must be received in writing by email.

In the event of postponement or cancellation, a full refund will be given. The University of Florida is not responsible for travel arrangements, travel fees, or any expenses incurred by you as a result of such a cancellation. If the University of Florida cancels this event, you will be contacted at the email address you provided, so please be sure to provide a valid email address.

Accommodations for Disabilities or Special Requests, Including Dietary
If you have needs that require special accommodations, including dietary concerns, please contact the CME Office.

For activity related questions, please contact
Name: Anastacia Cantrell
Email: [email protected]

For CME general questions, please contact
Email: [email protected]

You are not logged in.

Please click the button below to login or create a new account before continuing.

Mitigation of Relevant Financial Relationships

University of Florida College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control a CME activity's content, including faculty, planners, reviewers, and/or others, must disclose all financial relationships with ineligible companies (commercial interests). Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure. No one else in a position to control content has any financial relationships to disclose. All relevant financial relationships have been mitigated.

Exhibit at this Event